Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM. (Q51582004)
Jump to navigation
Jump to search
scientific article published in April 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM. |
scientific article published in April 1996 |
Statements
1 reference
Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM. (English)
1 reference
O G Kolterman
1 reference
S Schwartz
1 reference
C Corder
1 reference
B Levy
1 reference
L Klaff
1 reference
J Peterson
1 reference
A Gottlieb
1 reference
1 April 1996
1 reference
1 reference
39
1 reference
4
1 reference
492-499
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference